Nuclear receptor-binding sites of coactivators glucocorticoid receptor interacting protein 1 (GRIP1) and steroid receptor coactivator 1 (SRC-1): multiple motifs with different binding specificities.
暂无分享,去创建一个
[1] H. Gronemeyer,et al. The coactivator TIF2 contains three nuclear receptor‐binding motifs and mediates transactivation through CBP binding‐dependent and ‐independent pathways , 1998, The EMBO journal.
[2] David M. Heery,et al. A signature motif in transcriptional co-activators mediates binding to nuclear receptors , 1997, Nature.
[3] Christopher K. Glass,et al. The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function , 1997, Nature.
[4] M. Garabedian,et al. GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors , 1997, Molecular and cellular biology.
[5] M. Ptashne,et al. Transcriptional activation by recruitment , 1997, Nature.
[6] K. Yamamoto,et al. Three Amino Acid Substitutions Selectively Disrupt the Activation but Not the Repression Function of the Glucocorticoid Receptor N Terminus* , 1997, The Journal of Biological Chemistry.
[7] F. Jeanmougin,et al. A possible involvement of TIF1 alpha and TIF1 beta in the epigenetic control of transcription by nuclear receptors. , 1996, The EMBO journal.
[8] J. Chrivia,et al. CREB-binding Protein Activates Transcription through Multiple Domains* , 1996, The Journal of Biological Chemistry.
[9] D. Livingston,et al. The nuclear hormone receptor coactivator SRC-1 is a specific target of p300. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[10] K. Horwitz,et al. Nuclear receptor coactivators and corepressors. , 1996, Molecular endocrinology.
[11] R. Roeder,et al. The role of general initiation factors in transcription by RNA polymerase II. , 1996, Trends in biochemical sciences.
[12] R. Tjian,et al. TAFs mediate transcriptional activation and promoter selectivity. , 1996, Trends in biochemical sciences.
[13] B. Howard,et al. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A , 1996, Nature.
[14] P. Chambon,et al. TIF2, a 160 kDa transcriptional mediator for the ligand‐dependent activation function AF‐2 of nuclear receptors. , 1996, The EMBO journal.
[15] B. Pugh,et al. Mechanisms of transcription complex assembly. , 1996, Current opinion in cell biology.
[16] M. Stallcup,et al. GRIP1, a novel mouse protein that serves as a transcriptional coactivator in yeast for the hormone binding domains of steroid receptors. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[17] Thorsten Heinzel,et al. A CBP Integrator Complex Mediates Transcriptional Activation and AP-1 Inhibition by Nuclear Receptors , 1996, Cell.
[18] R. Evans,et al. The RXR heterodimers and orphan receptors , 1995, Cell.
[19] L. Guarente,et al. Transcriptional coactivators in yeast and beyond. , 1995, Trends in biochemical sciences.
[20] B. O’Malley,et al. Sequence and Characterization of a Coactivator for the Steroid Hormone Receptor Superfamily , 1995, Science.
[21] P. Kushner,et al. Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. , 1995, The EMBO journal.
[22] P. Chambon,et al. The N‐terminal part of TIF1, a putative mediator of the ligand‐dependent activation function (AF‐2) of nuclear receptors, is fused to B‐raf in the oncogenic protein T18. , 1995, The EMBO journal.
[23] P. Webb,et al. Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens. , 1995, Molecular endocrinology.
[24] G. Sprague,,et al. Protein-protein interactions in the yeast pheromone response pathway: Ste5p interacts with all members of the MAP kinase cascade. , 1994, Genetics.
[25] P. Chambon,et al. Activation function 2 (AF‐2) of retinoic acid receptor and 9‐cis retinoic acid receptor: presence of a conserved autonomous constitutive activating domain and influence of the nature of the response element on AF‐2 activity. , 1994, The EMBO journal.
[26] Michael R. Green,et al. Nuclear protein CBP is a coactivator for the transcription factor CREB , 1994, Nature.
[27] Tom Maniatis,et al. Transcriptional activation: A complex puzzle with few easy pieces , 1994, Cell.
[28] M. Beato,et al. Steroid hormone receptors: interaction with deoxyribonucleic acid and transcription factors. , 1993, Endocrine reviews.
[29] D. Reinberg,et al. Regulation of RNA polymerase II transcription. , 1993, Current opinion in cell biology.
[30] J. Baxter,et al. The limits of the cellular capacity to mediate an estrogen response. , 1992, Molecular endocrinology.
[31] K. Umesono,et al. Determinants of target gene specificity for steroid/thyroid hormone receptors , 1989, Cell.
[32] R. Evans,et al. Multiple and cooperative trans-activation domains of the human glucocorticoid receptor , 1988, Cell.
[33] R. Evans,et al. The steroid and thyroid hormone receptor superfamily. , 1988, Science.
[34] S. Green,et al. A versatile in vivo and in vitro eukaryotic expression vector for protein engineering , 1988, Nucleic Acids Res..
[35] P. Chambon,et al. Functional domains of the human estrogen receptor , 1987, Cell.
[36] R. Harrison,et al. Characterization of wild type and mutant glucocorticoid receptors from rat hepatoma and mouse lymphoma cells. , 1985, The Journal of biological chemistry.
[37] C. Glass,et al. Nuclear receptor coactivators. , 2000, Advances in pharmacology.
[38] B. O’Malley,et al. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. , 1994, Annual review of biochemistry.
[39] K. Yamamoto,et al. Glucocorticoid receptor mutants that are constitutive activators of transcriptional enhancement , 1987, Nature.